About
NetwoRx Bio is unlocking the next generation of immunotherapy. We harness cutting-edge computational biology to decode the complex communication networks between immune, tumor, and stromal cells within the tumor microenvironment—revealing how these interactions drive treatment response and resistance.
Powered by proprietary data from our clinical trials and advanced AI-driven analytics, we generate the NetwoRx Score: a patient-specific metric that identifies the most actionable molecular interactions. This score predicts response to immune checkpoint inhibitors (ICIs), monoclonal antibodies, and small molecule immune modulators—transforming complexity into precision.
Our Value Proposition:
1. Optimal Clinical Trial Design Matching the right immunotherapeutic drugs or combinations to the right indication and patient population—enhancing trial success and development efficiency.
2. Precision Medicine Delivering personalized immunotherapy by identifying which patients are most likely to benefit from specific treatments.
NetwoRx Bio turns the hidden communication networks of the tumor microenvironment into a roadmap for smarter, faster, and more effective immunotherapy.
Q&A
- What is NetwoRx Bio's primary focus?
- NetwoRx Bio is focused on revolutionizing immunotherapy trials by using AI-driven insights to decode communication networks within the tumor microenvironment, aiming to improve treatment response and resistance.
- When was NetwoRx Bio founded?
- NetwoRx Bio was founded in May 2024.
- What is the current employee count for NetwoRx Bio?
- NetwoRx Bio currently has 1-10 employees.
- What technology does NetwoRx Bio utilize?
- NetwoRx Bio utilizes Biologicals and Artificial Intelligence in its operations.
- What is the main product or service offered by NetwoRx Bio?
- NetwoRx Bio generates the NetwoRx Score, a patient-specific metric derived from proprietary clinical trial data and AI analytics, to predict response to various immunotherapeutic treatments.
- What is NetwoRx Bio's current funding stage?
- NetwoRx Bio is currently in the Pre-Funding stage.
- Does NetwoRx Bio hold any patents?
- Yes, NetwoRx Bio holds 1 patent.
- What is NetwoRx Bio's primary sector?
- NetwoRx Bio's primary sector is Health Tech & Life Sciences.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | networx.bio/ |
|---|---|
| linkedin.com/company/107054316/ |
Identifiers & details
| Former names | Pyxis Dx |
|---|---|
| Founded | 2024-5 |
| Employees (exact) | 5 |
Radar intelligence
Web history (Wayback)
| Domain | networx.bio |
|---|